Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Natalie Grinshtein, Constanza C. Rioseco, Richard Marcellus, David Uehling, Ahmed Aman, Xueqing Lun, Osamu Muto, Lauren Podmore, Jake Lever, Yaoqing Shen, Michael D. Blough, Greg J. Cairncross, Stephen M. Robbins, Steven J. Jones, Marco A. Marra, Rima Al-Awar, Donna L. Senger, David R. Kaplan
Published Jul 18, 2016 · Vol. 7, No. 37 · pp. 59360-59376
Andreas Kirschner, Melanie Thiede, Franziska Blaeschke, Günther H.S. Richter, Julia S. Gerke, Michaela C. Baldauf, Thomas G.P. Grünewald, Dirk H. Busch, Stefan Burdach, Uwe Thiel
Published Jul 18, 2016 · Vol. 7, No. 35 · pp. 56584-56597
Yvonne Möller, Markus Morkel, Jens Schmid, Sven Beyes, Janina Hendrick, Michaela Strotbek, Pamela Riemer, Simone Schmid, Lisa C. Schmitt, Roland Kontermann, Thomas Mürdter, Matthias Schwab, Christine Sers, Monilola A. Olayioye
Published Jul 18, 2016 · Vol. 7, No. 33 · pp. 53526-53539